Before the bump: Can pre-pregnancy planning affect child development?
The preconception period is often overlooked by prospective parents, but is crucial as it sets the foundation for healthy pregnancies and, ultimately, thriving children. Optimizing the physical and mental health of both parents during this time can help create an environment that gives their offspring the best possible start in life.
While it's well known that exposure to adverse physical or psychological conditions during pregnancy can powerfully affect child development, emerging evidence suggests that factors occurring before conception can also have lasting effects on offspring.
As professors of child development and perinatal psychiatry, our work is aimed at identifying which preconception factors have the potential to influence offspring outcomes, and how to intervene to reduce their effects to give all children the best chance to succeed and thrive.
The period of pregnancy planning represents a critical opportunity for future parents to optimize the lives of their children. While some physical and mental health factors shift over time, others are relatively stable. Regardless, enhancing physical and psychological health months or even weeks before conception may have powerful positive effects on offspring.
For example, public health authorities recommend that women of childbearing age take a folic acid supplement, as this can prevent neural tube defects and enhance the long-term verbal and social skills of offspring.
Maintaining a healthy diet (for example, eating plenty of fruits, vegetables, whole grains and protein) and a healthy weight before pregnancy is also associated with a lower risk of behavioural problems, improved motor and communication skills and better academic achievement.
Ultimately, optimizing one's physical health has many benefits for parents and their children and paves the way for improving their mental health as well.
Even though planning a pregnancy may be stressful for some, optimizing one's mental health has benefits not only for parents, but also for their future children.
For example, children whose mothers experience a worsening of depression from preconception to postpartum were less able to control their behaviour and attention. Furthermore, high levels of stress in mothers pre-conceptually are linked to more negative emotionality and impulsivity in children.
As a result, increasing the focus of public health efforts on the mental health of parents could be crucial to enhancing child development as well.
Even though the health of mothers and birthing parents can have an important impact on the development of future offspring, healthy partners can also help promote positive long-term outcomes in children.
For example, paternal mental health problems present prior to pregnancy increase the risk of pre-term delivery, which is linked to a higher likelihood of behavioural problems and academic difficulties in children later in life.
Partners can also provide support and motivation to improve and/or maintain the healthy habits of mothers and birthing parents, which can help optimize offspring development.
A number of practical steps can be taken by parents when planning a pregnancy to help enhance child development.
Eating a healthy diet and engaging in regular exercise can improve your physical health.
Optimizing mental health through exercise, nurturing relationships, building social networks, managing stress and seeking counselling and other help when needed can promote well-being during this important time.
Research aimed at understanding the long-term effects of preconception conditions on later child development is still relatively new. Our work is attempting to expand this knowledge base by developing a cohort study that begins in the preconception phase and follows parents throughout pregnancy and into the postpartum period.
So far, more than 500 women across Canada have joined the study, and we are continuing to enrol new participants until the end of August 2025. Please note that the web page is in French, but English speakers are welcome to join the study. However, since all research materials are in French, participants must be able to understand written French to take part in the study.
Our work will examine how parents' mental health evolves across the perinatal period. This study is intended to help us understand the transition to parenthood and how factors present before conception can influence children's development.
The pregnancy planning period is a time when parents can make positive changes in their lives that can benefit their health and the development of their future children. Investing in the physical and mental health of both parents is critical for preparing them to welcome a healthy child and can benefit both their family and society.
This article is republished from The Conversation, a nonprofit, independent news organisation bringing you facts and trustworthy analysis to help you make sense of our complex world. It was written by: Sabrina Faleschini, Université Laval and Ryan Van Lieshout, McMaster University
Read more:
What to expect when you're expecting: How will your sex life change during pregnancy and postpartum?
Planning for a baby? Why both men and women should consider quitting alcohol before and during pregnancy
Returning to exercise postpartum: Supporting women's physical activity after the birth of a child
Sabrina Faleschini receives funding from the Fonds de recherche du Québec - Société et culture.
Ryan Van Lieshout does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
13 minutes ago
- Yahoo
GSK climbs after winning FDA priority review for oral gonorrhoea antibiotic
-- GSK (NYSE:GSK) (LON:GSK) said on Monday that the U.S. Food and Drug Administration has accepted its priority review application for gepotidacin, an oral antibiotic aimed at treating sexually transmitted uncomplicated gonorrhoea. The drugmaker's shares climbed 1% in London on the news. The company is looking to new infectious disease products, including its recently launched respiratory syncytial virus vaccine, to offset expected revenue declines from top-selling medicines and looming patent expirations in its HIV portfolio. Gepotidacin is already approved in the U.S. under the brand name Blujepa for treating a common urinary tract infection in women and adolescent girls. The FDA is expected to decide in December on its use for uncomplicated urogenital gonorrhoea, which could offer patients an oral alternative to existing injectable treatments. Separately, GSK and Germany's CureVac last week resolved a long-running patent dispute with Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) over mRNA vaccine technology used during the COVID-19 pandemic. The settlement follows BioNTech's June agreement to acquire CureVac in an all-stock deal worth $1.25 billion to advance work on mRNA-based cancer therapies. Under the settlement, CureVac and GSK will receive $740 million and single-digit percentage royalties on future U.S. sales of COVID-19 vaccines, CureVac said. GSK's share amounts to $370 million, including $50 million to adjust terms from a 2024 licence agreement that expanded their pandemic-era partnership. If BioNTech's takeover of CureVac is completed, related mRNA litigation outside the U.S. will also be resolved, with GSK receiving an additional $130 million and royalties extended to non-U.S. sales. CureVac said the acquisition remains on track under the agreed terms. GSK said it still has separate patent cases against Pfizer and BioNTech in the U.S. and Europe, which are unaffected by this settlement. Related articles GSK climbs after winning FDA priority review for oral gonorrhoea antibiotic USPS blocks major vape distributor over unregulated product shipments - Reuters Exclusive: Opendoor CEO Wheeler breaks silence, EMJ's Eric Jackson calls for more Sign in to access your portfolio
Yahoo
43 minutes ago
- Yahoo
Patient's heartbreaking final words before death
"I want to go home." These were the last words spoken to a father by a young woman who died within hours of complications arising from elective weight loss surgery. Brooke Tiddy was admitted to St George Private Hospital in Sydney on September 19, 2018 for bariatric surgery recommended by her doctor, who assessed her as "super super obese". But her hopes for a new lease on life were dashed when the 32-year-old died two days later. An inquest into her death seeks to assess the effectiveness of the hospital's processes and prevent similar deaths. On Monday, her parents and two sisters remembered the mental health support worker as "an energetic and enthusiastic soul who would do anything for anyone". Ms Tiddy had been "deeply motivated to improve her health" and was "nervous but excited" when she embarked on the journey "she would never have a chance to complete". Her family said the passionate baker's life was cut tragically short by a failure to investigate her underlying health issues before her surgery. "This oversight cost Brooke her life and shattered her family's and friends' trust in the health system," they said in a statement. "We hope (this inquest) will lead to measures that ensure such preventable tragedies never happen again". The inquest was told Ms Tiddy lived with an "extremely rare" condition known as sponastrime dysplasia, which affects the muscles and skeletal system. Her surgeon Dr Vytauras Kuzinkovas said he hadn't previously heard of the condition and didn't do any research about it until after Ms Tiddy's death. One of the associated features is a narrowing of the airways which was ultimately found to be Ms Tiddy's cause of death, the inquest was told. An autopsy found her airways had severely narrowed to the approximate diameter of a drinking straw, which almost certainly occurred before the surgery. Dr Kuzinkovas said Ms Tiddy downplayed her asthma and depression and didn't reveal she had croup or narrow airways during an initial consultation. An in-depth assessment of her medical history would have likely revealed such risk factors, he said, but he hadn't thought it was needed at the time. With the benefit of hindsight, Dr Kuzinkovas accepted Ms Tiddy was a high-risk patient whom he would have referred to specialists before surgery. Intensive care unit staff looking after Ms Tiddy were not informed about her sponastrime dysplasia and its significance, the inquest was told. If he had been aware of the link between her condition and narrowed airways, ICU doctor Michael O'Leary said he would have called in a specialist. "This has been the worst experience I've had in my career. I felt very alone that night," he said. "The only thing looking back on it I would do differently would be to get someone else to give me a hand." Dr O'Leary said he wasn't sure whether a pre-operative assessment would have prevented MsTiddy's death because what they really needed was to access her full medical history. "In a sense we were set up to fail in this case because there was all of this information that was kept from us," he said. The inquest continues on Tuesday.


Medscape
44 minutes ago
- Medscape
Canadians Launch Country's First Black Medical Journal
The launch of Canada's first Black medical journal has been welcomed by the Black community as a major step towards promoting diversity in healthcare research. The Nigerian Canadian Medical Journal was launched on August 2 in Edmonton by the Canadian Association of Nigerian Physicians and Dentists (CANPAD). Hadal El-Hadi, MD 'This new journal can make a significant difference in addressing the health and social issues faced by Black Canadians,' Hadal El-Hadi, MD, founder of Black Physicians of Canada, told Medscape Medical News. 'By providing a dedicated platform for research, scholarship, and dialogue, it can elevate the voices of Black scholars and practitioners.' El-Hadi, who is not involved in the journal, added that it could further play a role in highlighting critical health disparities, promoting culturally relevant research, fostering interdisciplinary collaborations, and serving as a resource to guide the development of effective interventions and strategies that are tailored to the unique needs of Black communities. Journal to Fill Minority Gaps in Research The journal's editor-in-chief, Moses Ademola, MD, explained to Medscape Medical News that the aim was to create a peer-reviewed, open-access publication that provides fresh insights and a new global perspective that appeals to readers within and beyond the Nigerian community. 'We know from working around different teams that a diverse team improves outcomes for our patients, who, increasingly, are coming to us in diverse forms,' said Ademola, who is an emergency physician at Sturgeon Community Hospital, St. Albert, Alberta, and Royal Alexandra Hospital in Edmonton. 'The CANPAD journal was formed to enrich medical discourse, offer mentorship, and foster collaborative research. While the journal is published by a Black committee, it's aimed at a broad global audience. It's our hope and prayer that it will reflect the multicultural and inclusive values of Canada. We'll follow the science and go where we feel we can make a difference. We want to be a platform for voices that would otherwise be missed,' Ademola explained. Black Canadians Face Health Inequities A Government of Canada public health agency study published in 2020 reported that racism has been increasingly recognized as an important driver of inequitable health outcomes for visible minority Canadians. 'The healthcare challenges faced by Black Canadians are distinct due to historical factors, including the legacy of colonialism and systemic racism, which create unique barriers to care,' said El-Hadi. 'Black patients can experience discrimination within healthcare settings, leading to mistrust and inadequate treatment. Additionally, cultural differences in health perceptions and the stress from ongoing racism contribute to disparities in health outcomes,' she said. Lack of inclusion and diversity continues to be a source of concern for the Black community and public health organizations. 'Research gaps and health inequalities exist, and some of these are not modifiable,' explained Ademola. 'The Irish population tends to have cystic fibrosis. Blacks have a disproportionately high incidence of sickle cell disease. And Ashkenazi Jews are enriched for carriers of a fatal form of Tay-Sachs disease.' If clinicians aren't equipped to manage them well, the outcomes tend to be poorer, he said. El-Hadi said there is a need for focused research on chronic diseases within Black communities, particularly concerning the impact of racism and stress. Historically, the Black population in Canada and globally has been underrepresented in clinical research in terms of participation in clinical trials, as researchers, and in access to funding. Health studies often lack sufficient representation of Black Canadians, limiting understanding of their specific health needs. Cultural differences in health behaviors are also often overlooked, skewing data applicability. 'The medical community will have to work harder to ensure we don't end up with an unintended racial bias. The government must be intentional in ensuring that equity gaps are bridged. Scholars and scientists everywhere have to be aware of this blind spot. We need to work together so that health outcomes in all our population are similar,' said Ademola. Canada's Social Sciences and Humanities Research Council developed a work plan in 2020 to address anti-Black racism in research, leading to the establishment of an external advisory committee of Black researchers. The council says it aims to ensure that Black researchers have fair access to research support and is working with stakeholders to advance their equitable participation in the research ecosystem. Ademola and El-Hadi reported having no relevant financial relationships.